Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NUVB is expected to report earnings to fall 5.44% to -15 cents per share on March 05
Q4'25
Est.
$-0.15
Q3'25
Beat
by $0.01
Q2'25
Est.
$-0.17
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.01
The last earnings report on November 03 showed earnings per share of -15 cents, beating the estimate of -17 cents. With 5.77M shares outstanding, the current market capitalization sits at 1.61B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NUVB showed earnings on November 03, 2025. You can read more about the earnings report here.